Fierce Healthcare December 13, 2022
Heather Landi

As it moves forward with plans to fully sequence the genomes of at least 1 million people across the U.S., the National Institutes of Health’s (NIH’s) All of Us study is changing the research paradigm.

As promised, the All of Us research program has begun returning personalized health-related DNA results to participants, marking the largest-scale effort to date to share hereditary disease risk and pharmacogenetic information with study participants, according to NIH officials.

By returning health-related DNA information to participants, NIH is turning research into a “two-way street—fueling both scientific and personal discovery that could help individuals navigate their own health,” said Josh Denny, M.D., CEO of the All of Us program.

“This type of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
Patient-derived organoids: Transforming cancer research and personalized medicine

Share This Article